sizing by 3D TEE. Both CT and TEE were analyzed by experienced cardiologists. We compared clinical findings in these two groups. A composite end-point of 30-day major complications was defined as including death, cerebrovascular accident (CVA), myocardial infarction, cardiac shock, major bleeding, major vascular complications, acute kidney injury (AKI), and acute respiratory failure. Post-procedural para-valvular leak (PVL) and 30-day PVL were recorded by TEE and TTE respectively.
RESULTS There was no significant difference in the baseline mean eGFR (ml/min/1.73m3) in these two groups (33.0AE7.5 vs 28. 6AE10.8, p¼0.20) . Total number of patients with 30-day major complications in the low-dose contrast CT group were significantly lower than the 3D TEE based group (0% vs 18.5%, p<0.05), while there was no significant difference in post procedural PVL and 30-day PVL. In the ultra-low contrast group, there was no AKI and serum creatinine did not change after the CT scan (pre-scan creatinine 1.55AE0.21 mg/dl, post-scan creatinine 1.45AE0.40 mg/dl, p¼0.21).
CONCLUSIONS TAVR in patients with CKD by planning with ultra-low contrast dose CT was associated with similar post procedural PVL and 30-day PVL but with lower incidence of 30-day major complications compared to the 3D TEE group. Our results offer preliminary data that ultra-low dose contrast CT appears feasible and safe to guide TAVR procedures in patients with CKD. BACKGROUND Noninvasive methods to derive fractional flow reserve from coronary CT angiography data depend on the accuracy of the luminal boundary extracted from image data. The spatial resolution of coronary CTA data has been considered as a fundamental upper limit on the accuracy and precision of FFRCT, but this neglects the fact that CT image data can be segmented with sub-pixel resolution. We hypothesize that the quality of the image data and coronary calcification have a greater influence on lumen accuracy rather than the spatial resolution of CTA. We investigate the limits of the accuracy of lumen boundary identification from CT related to coronary calcification using OCT data as the reference standard.
METHODS Image processing methods were applied to segment the lumen boundaries of 96 lesions in 23 patients from coronary CTA and OCT data. Plaques were characterized as calcified or non-calcified based on appearance on CT. OCT data was co-registered to CT data using branch vessels found in both images as fiducial markers.
RESULTS Minimum lumen area was 3.47AE2.09 mm 2 (CT) and 3.58AE2.03 mm2 (OCT) for all plaques (p¼N.S.), and the average absolute error for MLA was 0.86 AE 0.67 mm 2 and 0.26 AE 0.19 mm for MLD. For noncalcified plaques, the average absolute error for MLA was 0.48 AE 0.31 mm 2 and 0.18 AE 0.10 mm for MLD, the Pearson's correlation coefficient for MLA by CT to MLA by OCT was 0.96 and the bias was -0.04 mm2.
CONCLUSIONS The spatial resolution of coronary CT angiography does not limit the accuracy of the lumen boundary extracted using modern image segmentation methods. Given a spatial resolution of CT data of approximately 0.4 x 0.4 x 0.6 mm, the MLD can be resolved accurately as evidenced by the strong correlation with OCT data for non-calcified plaques. Limitations in anatomic resolution are due to image quality, especially related to the presence of calcium. BACKGROUND Current catheter-based coronary imaging systems are calibrated to measure a distance from the probe to a lumen border through blood or a flushing medium with known signal propagation speed. Thus, presence of instent neointima may affect stent measurements, since the speed of signal can vary in soft tissue. Blooming artifacts from strongly-reflective metal struts can also result in a certain variability, particularly in light-based approaches. This study aimed to elucidate potential factors affecting stent measurements in comparison of conventional IVUS and optical frequency domain imaging (OFDI).
METHODS IVUS and OFDI were compared in 64 matched segment images obtained in vivo from 20 swine coronary stent models: 34 images were obtained at baseline, 17 images at 4 weeks, and 13 images at 12 weeks (corresponding to 6-and 18-month follow-up in humans, respectively). IVUS measurements were performed at the leading edge of boundaries, as ultrasound blooming mainly occurs distally. In OFDI where blooming can occur both proximally and distally at strut surface, stent contours were traced at leading edges and at highest intensity points of strut images.
RESULTS When stent was traced at leading edges of OFDI strut images, stent volume (mm 3 /mm) by OFDI was 2.6% smaller at baseline (p<0.001), 5.1% larger at 4 weeks (p<0.001), and equivalent at 12 weeks, compared with those obtained by IVUS. In contrast, when traced at highest intensity points by OFDI, stent volume was larger in OFDI than in IVUS at all time points but to varying degrees: 2.4% at baseline (p<0.001), 10.9% at 4 weeks (p<0.001), and 3.6% at 12 weeks (p¼0.01). Similar findings were also observed for minimum stent area measurements. In the assessment of instent neointima at follow-up, neointimal volume by OFDI was larger at both 4 weeks and 12 weeks than IVUS, regardless of the strut tracing methods, possibly due to indistinct neointimal border on IVUS images leading to underestimation of neointima particularly in stents with a relatively thin neointimal layer. 
